MSD Polska sp. z o.o.

Advertising agencies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-11-21
Share capital
6,060,000.00 PLN
Activity description

MSD Polska is part of a global biopharmaceutical company that conducts research and develops therapies for people and animals. It works on cancer medicines, vaccines and antibiotics targeting drug-resistant bacteria, and partners with Polish research centers and public institutions.

Registered address
Chłodna 51, 00-867 Warszawa, Poland
Website
Email
Phone
Social media
Electronic delivery address
AE:PL-27265-30278-TAFEH-24

Financials

Total Operating Costs
93.63m
+12.4% vs 2024

Revenue history (in m)

From the notes

Current income tax (CIT due)$1,039,601
Profit allocationRetained in reserve capital
Events after the balance sheet dateYes
Parent companyMSD Human Health Holding B.V.

Filing timeliness

Financial statements were filed on time, on average 92 days early. All were audited by a statutory auditor.

  • 202526/05/2026
  • 202416/05/2025
  • 202330/04/2024
  • 202205/05/2023
  • 202109/05/2022
  • 202002/03/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Advertising agencies7 / 3,958
Top <1%
City · Warszawa656 / 56,772
Top 1.2%
Voivodeship · Mazowieckie839 / 76,953
Top 1.1%
Country · Poland2,329 / 297,266
Top <1%

Results vs industry

Revenue
This companyUSD 99.37mMedianUSD 115.74kAverageUSD 1.12m
Net profit
This companyUSD 4.01mMedianUSD 4.00kAverageUSD 75.37k
Operating costs
This companyUSD 93.63mMedianUSD 100.82kAverageUSD 1.02m
Assets
This companyUSD 39.96mMedianUSD 57.44kAverageUSD 671.69k

Websites

The company has 6 websites. Most of them run on WordPress. The company uses the Meta advertising pixel (Facebook, Instagram).

  • msd.plHome – MSD Polska
    WordPressGoogle Tag ManagerYoast SEONginx
  • hpv.plHPV | szczepienia przeciw HPV dla dzieci i dorosłych
    WordPress 7.1ElementorGoogle Tag ManagerMeta PixelYoast SEOLiteSpeed
  • mojawstazka.plStrona główna – portal onkologiczny | Moja Wstążka

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2006.

MarkNumberClassesStatusProtected until
ZADBAJ O ŻYCIE - ZASZCZEP SIĘ PRZECIWKO RAKOWI SZYJKI MACICY (word)Z.3196465, 9, 16, 35, 44Refused –
Chronię życie przed rakiem szyjki macicy www.hpv.pl Z.3068595, 9, 16, 35, 44Expired –
MarkProtected until
ZADBAJ O ŻYCIE - ZASZCZEP SIĘ PRZECIWKO RAKOWI SZYJKI MACICY (word)–
Chronię życie przed rakiem szyjki macicy www.hpv.pl –

Authorized Representatives

Barbara Trolet Ép. Fillol – Management Board Member
Justin Gandy – President of the Management Board
Marcin Kokoszka age 48 – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Msd Human Health Holding B.v.
12,120$1,636,953.00100%

Beneficial owners

Person

Capital group

The company belongs to the Merck & CO., Inc. (United States) group. Its direct owner is MSD Human Health Holding B.V. (Netherlands). The group has 24 companies, 22 of them abroad.

NameCountry
Allflex India Private LimitedIndia
Intervet India Private LimitedIndia
Merck Global Health Innovation Fund, LLCUnited States
Merck Holdings LLCUnited States
Merck International Holdings LLCUnited States

Bank accounts

Registered as a VAT taxpayer on 2004-02-18.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 1.3M

MSiG notices

Publication dateEvent
Apr 13, 2011Merger registered
Jan 17, 2011Merger plan

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Astrazeneca Pharma Poland sp. z o.o.
Takeda Pharma sp. z o.o.
Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Teva Pharmaceuticals Polska sp. z o.o.
Sandoz Polska sp. z o.o.
Chiesi Poland sp. z o.o.
Synoptis Pharma sp. z o.o.
Solinea sp. z o.o.
Celon Pharma S.A.

Change history

DateEvent
2017-07-27PKD change
2011-03-31Share capital increase
2011-03-31Switch to PKD 2007
2005-01-04Address change
2004-09-15Share capital increase

FAQ

Last updated: 2026-10-07